Publications from America - CML - Chronic Myeloid Leukemia

NCCN Guidelines for Patients: CML Version 1.2011
2011, NCCN

Monitoring response and resistance to treatment in chronic myeloid leukemia
2011, Current Oncology

Effects of Selected Natural Health Products on Drug Metabolism:
Implications for Pharmacovigilance
2011, University of Ottawa

BCR-ABL Testing and IS Standardization featuring Dr. Richard Press
March 31, 2011, Oregon Health and Science University (OHSU)

Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center

NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous leukemia
February 2011, JNCCN

Molecular Testing in Chronic Myelogenous Leukemia: Diagnosis, Monitoring and Resistance
March 2007, Adam Bagg, University of Pennsylvania, Philadelphia

Pratical Management of Patients With Chronic Myeloid Leukemia Receiving Imatinib
2003, Amerian Society of Clinical Oncology